The thioxopyridine derivative (2) on treatment with ethyl chloroacetate gave the corresponding ethyl 3-aminothieno [2,3-b] 
I. INTRODUCTION
In the last several decades, pyridothienopyrimidine derivatives have received considerable attention due to their wide-range of applications.Pyridothienopyrimidines are reported to exhibit anticancer [1] [2] [3] , anti-inflammatory [4, 5] antimalarial [6] , anti-allergy [7] , anti-microbial [8] [9] , antifilarial [10] . Insecticidal activities [11] , also as V.E. GFR-2-inhibitors [12] . Moreover, as inhibitor of CLKI and Dy RKIA kinases [13] . Encouraged by these reports, it was considered of interest to of synthesizing a new series of pyridothienopyrimidine derivatives as potential antitumor agents.
II. EXPERIMENTAL
All melting points are uncorrected. IR spectra (KBr) were recorded with a Perkin Elmer Spectrum RXIFT-IR systems. 1 HNMR were measured with a Varian Gemini 200 MHz instrument using TMS as internal standard and mass spectra were measured with a Shimadzu GC-MS-QP 100 EX mass spectrometer .
Synthesis of 3-(4-bromophenyl)-2-cyanoprop-2-enethioamide (1)
A mixture of 4-bromobenzaldehyde (0.01 mol), thiocyano-acetamide (0.01 mol) and (0.002 mmol) of piperidine in ethanol (50 ml) was heated under reflux for 6hr., the solid separated after concentration and cooling was filtered off, and crystallized from benzene 98% yield. m.p. 155C IR., cm -1 , 3413, 2950, 2215 and 1239 for NH 2 , CH aliphatic, CN and C=S group, respectively. Analysis for C 10 
Synthesis of ethyl 4(-4-bromophenyl)-5-cyano-1,6-dihydro-2-methyl-6-thioxopyridin-3-carboxylate (2).
A mixture of 1(0.01 mol), ethyl acetoacetate (0.015 mol) and (0.002 mmol) of piperidine in dioxane (50 ml) was heated under reflux for 6 hr. The reaction mixture was concentrated and cooled. The separated solid was filtered off, and crystallized from benzene 90% yield, m.p. 100C, IR, cm - 
Synthesis of ethyl 3-(2-aminophenyl)-9-(-4-bromophenyl)-2,7-dimethyl-4-oxo-3,4-dihydropyrido-[3',2':4,5] thieno[3,2-d]pyrimidin-8-carboxylate(7).
A solution of compound 6 (0.01 mol) in acetic anhydride and acetic acid (5 ml) was heated under reflux for (5hr 
Synthesis of thienopyrimidine derivatives (8 a,b )
A mixture of compound 5b (0.01 mol), (maleic and/or phthalic anhydride) was heated in an oil bath for (1hr). The reaction mixture was diluted with water and the obtained solid was filtered off, dried and crystallized from ethanol to give compounds (8 a,b ), respectively. A mixture of compound 5 b (0.01 mol), ethyl chloroacetate (0.04 mol) and anhydrous potassium carbonate (0.04 mol) in dry acetone (30 ml) was refluxed for (24hr), the excess acetone was evaporated and the reaction mixture was diluted with water, the solid that separated was crystallized from acetone, 80% yield, m. 
Ethyl-9-(4-bromophenyl

Synthesis of ethyl 9-(4-bromophenyl)-3-(2-ethoxy-2-oxoethyl)-2,7-dimethy-4-oxo-3,4-dihydropyrido [3'2': 4,5] thieno [3,2-d] pyrimidin-8-carboxylate (13).
A mixture of compound 5 a (0.01 mol), ethyl chloroacetate (0.04 mol) and anhydrous potassium carbonate (0.04 mol) in dry acetone (30 ml) was refluxed for (24 hr), the excess acetone was removed by distillation and the residue poured with stirring into water, the obtained solid was filtered off, dried and recrystallized from ethanol 70% yield, m. 
Synthesis of ethyl 9 -(4-bromophenyl)3-(2-hydrazinyl-2-oxoethyl)-2,7-dimethyl-4-oxo-3,4-dihydropyrido[3',2':4,5]thieno[3,2-d]pyrimidin-8-carboxylate (14).
A mixture of compound 13 (0.01 mol), and hydrazine hydrate (0.02 mol) in ethanol (20 ml) was refluxed for (6hr), the reaction mixture was concentrated cooled and the obtained was filtered off and recrystallized from ethanol 80% yield, m. 
Synthesis of ethyl 9-(4-bromophenyl)-2,3,7-trimethyl-4-oxo-3,4-ihydropyrido[3',2':4,5]thieno[3,2-d]pyrimidin-8-carboxylate (16).
A mixture of compound 5 a (0.01 mol), methyl iodide (0.02 mol) and anhydrous potassium carbonate (0.04 mol) in dry acetone (40 ml) was refluxed on water bath for (24hr), the excess acetone water removed by distillation and the residue was poured with stirring into water, the obtained solid was filtered off, dried and recrystallized from acetone 60% yield, m.p. 155C. IR, cm -1 . CH aliphatic at 2971, CO(ester) at 1757 and CO(amidic) at 1639. 
Cytotoxicity assays
The cytotoxicity Was measured using the MTT (3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide) cell viability assay [15, 16] . In brief, cells were seeded in 96-well plates and treated with graded concentrations of tested compounds. Then the medium was replaced with fresh medium and cells were incubated with MTT. Four hours later, cells were lysed by addition of dimethylsulphoxide (DMSO). The solubilized formazan products were quantified for absorbance at a wavelength of 570 nm.
Cytotoxicity against the liver tumor cell line (HepG2) in vitro.
Compounds 2,3,4,5 b ,6,7,8 a ,8 b , 9,10,11,12,13, 14, 15 and 16 were evaluated for their human tumor cell growth inhibitory activity against HepG 2 (hepatocarcinoma). The measurement of cell growth and viability were determined as described previouse [15, 16] .
Cytotoxicity evaluation using viability assay were performed by a Regional Center for Mycology and Biotechnology (RCMP), Al-Azhar University. The inhibitory activity of the synthetic compounds against the liver carcinoma cell line (HepG2) is given in (Figs. 2, suplementry material) . The IC 50 values were in the low concentration in microgram range.
III. RESULTS AND DISCUSSION
The new derivatives were prepared following the reaction sequences depicted in schemes 1-3.
Reflux of p-bromobenzaldehyde and cyanothioacetamide in dioxanewith a catalytic amount of piperidine afforded arylidene cyanothioacetamide 1 in good yield.
Compound 1 reacts with ethyl acetoacetate in the presence of a catalytic amount of piperidine in boiling dioxane to produce the corresponding thioxopyridine derivative 2. The reaction probably follows through mechanism followed in chart 1. ( Fig1) . Surprisingly, compounds 8 a and 14 were more potent than the standard drug (IC 50 of standard drug = 4.60 g/ml) in HepG 2 cell line. Compounds 2,6 and 9 had moderate inhibitory activity against HepG 2 with IC 50 = 26.30g/ml, 5.45 g/ml and 11.10g/ml respectively. While compounds 3,4 b ,7, 8 b , 10,11,12,13,15 and 16 had weak activity. 
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IV. CONCLUSION In conclusion, the pyridothienopyrimidine with 3-(1H-1-pyrazol-1-yl) 8a, 3-((4-chlorobenzelidine)amino) 9 and 3-(2-hydrazinyl-oxo ethyl) 14 functions exhibited of some new heterocyclic compounds. Structure of the synthesized the most active compounds against HepG 2 as compared with the used standard drug.However, the remaining compounds exhibited moderate to lower antitumor activities.
